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What's already known about this topic? 
Naevi are known to change in colour and size during pregnancy and melanoma is 
the most common type of cancer in pregnant women. 
What does this study add? 
The clinical features, dermoscopic images and histopathological appearance of two 
slowly growing melanomas detected by sequential digital dermoscopy imaging 
during pregnancy are reported. 
 
Abstract 
Whether or not pregnancy favours the occurrence and growth of melanoma is a 
source of controversy in the literature. Several case reports have shown dramatic 
courses of diseases in pregnancy. We present a case of a 36-year-old woman with 
multiple naevi with one melanoma detected in 2009 in the first trimester and a 
second primary melanoma in 2010 in the third trimester of her pregnancy. Both 
lesions have been present for at least 5 years and have been interpreted as 
dysplastic naevi. Because of their growth during pregnancy they were removed. No 
metastatic disease has been found between 2010 and early 2016. This case shows 
the difficulty of detecting melanomas in pregnancy, particularly when they mimic 
dysplastic naevi in women with multiple naevi, who are at higher risk. Therefore, we 
suggest that pregnant women with numerous naevi should be precautious of any 
changes of their naevi in size, shape and colour. Every suspicious lesion should be 
either excised or documented/monitored carefully, e.g. with sequential digital 
dermoscopy imaging.  
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Background 
Melanoma incidence is rising worldwide and causes the majority of skin cancer 
related deaths.1 Besides the well-known risk factors of skin type, positive family 
history and genetic background there is ongoing discussion about whether or not 
pregnancy is a driver for the occurrence and growth of melanoma. In the 1950s 
several authors published cases of pregnant women with extraordinarily aggressive 
disease courses.2,3 However, studies investigating the role of oestrogen and 
progesterone did not find any influence on the growth of melanoma.4 In addition, 
older studies could not show an increased risk of death for women developing a 
melanoma in pregnancy. 
This case gives a unique insight in the changes of two lesions in pregnancy. 
 
Report of a Case 
A 36-year-old woman with more than 100 naevi, who was 15 weeks pregnant in her 
first pregnancy, recognized a naevus on her right inframammary region had changed 
colour (Figure 1E to 1F). As she had been having regular skin examinations 
including sequential digital dermoscopy imaging because of her dysplastic naevus 
syndrome, she presented herself at the Department of Dermatology, Medical 
University of Graz in November 2009. No family history of melanoma was recorded, 
but the patient had a family history of breast cancer. Clinical examination showed an 
irregular pigmented flat plaque with different brownish colours and a white centre. 
Dermoscopic evaluation revealed that the naevus had a newly grown atypical pattern 
represented by enlargement, signs of regression, and loss in symmetry (Figure 1F) 
compared to the digital dermoscopic images taken at the last visit in April 2009 
(Figure 1E). Diagnostic total excision of the suspicious lesion was performed and the 
diagnosis of melanoma was confirmed by histopathology (Breslow index, < 0.5 mm; 
mitotic index, < 1/mm2; pT1a AJCC 2009; BRAFV600E). At this examination, all other 
atypical naevi had similar clinical and dermoscopic features as in April 2009. At a 
follow-up appointment in April 2010 (37 weeks of pregnancy), another naevus on the 
posterior of her left foot had slightly changed in size, clinical and dermoscopic 
appearance compared to digital dermoscopy images taken in April 2009 (Figure 1K). 
Total excision was performed and histopathology, confirmed a second invasive 
melanoma (Breslow index < 0.5 mm; mitotic index < 1/mm²; pT1a AJCC 2009; 
BRAFwt). Histopathology for both melanomas showed no signs of an associated 
naevus. In May 2010 at gestation week 42, a healthy infant was born. In the five 
years since, the patient has been under close observation by our Department and 
has shown neither disease progression nor further melanomas. 
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Discussion 
Pregnancy associated malignant melanoma (PAMM) is the most common cancer 
during pregnancy with an incidence of 5 to 10 per 100.000 pregnancies.5 A meta-
analysis by Byrom et al. could show that PAMM has a poorer prognosis compared to 
non-pregnancy associated melanomas with a pooled hazard ratio of 1.56.6 A recent 
study conducted by Tellez et al. could further show a 5-fold increase in mortality and 
a 7-fold increase in metastasis in PAMM compared to non-PAMM.7 However, the 
underlying mechanisms by which pregnancy influences melanoma and melanocytic 
nevi are still under investigation and several factors may favour the emergence and 
growth of melanoma during pregnancy.  
Pregnancy-associated proteins such as oestrogen and progesterone are up-
regulated in pregnancy to maintain and support the growth of the foetus, and the 
occurrence of PAMM might be due to these proteins. It has been shown that several 
of these proteins have a proliferative effect, but due to the multiplicity of upregulated 
pregnancy-related proteins it is difficult to identify the hormone(s) responsible for this 
phenomenon.8,9 
Another possible mechanism is the reduced cellular immunity of pregnant women, 
which prevents the immune system of the mother attacking the foetus. Melanoma is 
a known immune system sensitive tumour, so pregnancy-associated 
immunosuppression may favour melanoma growth.10  
Finally Khosrotehrani et al. demonstrated in a mouse model that pregnancy induces 
lymphangiogenesis in melanoma.11 They also showed that pregnant mice had a 
significantly higher tumour volume compared to non-pregnant mice and in line with 
these results, the pregnant mice had also a significantly lower survival. A similar 
effect in humans might put pregnant women at higher risk of developing metastatic 
disease at earlier stages of their diseases. However Byrom et al. investigated the 
role of a subsequent pregnancy after previously treated non-pregnancy associated 
melanoma.12 Interestingly the authors could not find any significant influence on 
melanoma outcome which suggests that pregnancy after the diagnosis and 
treatment of melanoma does not put women at a higher risk for recurrence or 
mortality. 
During pregnancy a change in the colour of naevi is common due to hormonal 
influences, whereas an enlargement of naevi is mostly related to anatomic areas 
with physiological skin expansion.13 
In our patient, two slowly growing melanomas hidden by multiple dysplastic naevi 
and appearing as dysplastic naevi, showed changes after the onset of pregnancy. As 
evidenced by sequential digital dermoscopy imaging the rapid change in the first 
melanoma is more prominent than the subtle change in the second melanoma, and 
one might speculate that was due to pregnancy-related hormonal changes and the 
down-regulation of cellular immunity. However, this would not explain the fact there 
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were differences in the clinical appearance of the two melanomas. Perhaps the 
BRAF status of each melanoma has played a crucial role.  
We suggest that women with a higher risk of melanoma – e.g. more than 50 naevi or 
numerous dysplastic naevi - should be precautious of any changes of their naevi in 
size, shape and colour during pregnancy. The assessment of naevi in pregnancy is 
particularly challenging as many naevi, particularly on the abdomen and breasts, 
show changes in pigmentation and symmetrical growth in size. Sequential digital 
dermoscopy imaging as demonstrated in our case might be of help to assist 
dermatologists to meet this challenge. According to the database reprotox14 
Lidocaine as well as Bupivacaine can be used for local excisions during pregnancy, 
if necessary.  
 
Conclusions 
In conclusion slowly growing melanomas may occur during pregnancy and therefore 
every change in a naevus – especially apart from usual symmetrical enlargement of 
naevi on the abdomen and the breasts – should be taken very serious since a delay 
in diagnosis might have a negative influence on the outcome. 
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Figure 1. Development of the two lesions over a period of five years 
The upper lesion showed subtle changes before pregnancy (Figure 1D-E) and 
pronounced atypical growth patterns with enlargement during pregnancy (Fig. 1F) 
leading to diagnostic excision. The lower lesion had a continual change in its growth 
pattern over four years (Figure 1G-K), with a significant enlargement during 
pregnancy (Figure 1L) leading to second diagnostic excision (MoleMax, Derma 
Medical Systems, Vienna, Austria, magnification x30). 
 
Figure 2. HE staining of the first malignant melanoma (Magnification x4 (A), x10 (B) 
and x20 (C)). 
Superficial melanoma. There are atypical melanocytes singly and in nests at the 
dermo-epidermal junction and throughout the epidermis. In addition, there are also 
few small nests of atypical melanocytes in the papillary dermis. 
 
Figure 3. HE staining of the second malignant melanoma (Magnification x4 (A), x10 
(B) and x20 (C)). 
In situ part of the second melanoma: There is an increased number of atypical 
melanocytes singly and in small nests at the dermo-epidermal junction. Note there 
are also atypical melanocytes in the upper layers of the epidermis. 
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